- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 28, 2025 | 20.81M sh |
| Long Term Debt | Q1 2025 · Mar 28, 2025 | $398.74M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $407.73M |
| Short Term Debt | Q1 2025 · Mar 28, 2025 | $52.57M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $34.27M |
| Cash And Equivalents | Q1 2025 · Mar 28, 2025 | $15.63M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $16.71M |
| Current Liabilities | Q1 2025 · Mar 28, 2025 | $267.05M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $226.73M |
| Current Assets | Q1 2025 · Mar 28, 2025 | $759.04M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $724.22M |
| Total Assets | Q1 2025 · Mar 28, 2025 | $1.75B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.7B |
| Shares Diluted | Q1 2025 · Mar 29, 2024 | 20.97M sh |
| Dividends Paid | Q1 2025 · Mar 29, 2024 | $2.69M |
| Capex | Q1 2025 · Mar 29, 2024 | $21.31M |
| Operating Cash Flow | Q1 2025 · Mar 29, 2024 | −$13.81M |
| Stockholders Equity | Q1 2025 · Mar 29, 2024 | $889.92M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $885.05M |
| Eps Diluted | Q1 2025 · Mar 29, 2024 | $0.64 |
| Eps Basic | Q1 2025 · Mar 29, 2024 | $0.65 |
| Sga Expense | Q1 2025 · Mar 29, 2024 | $35.84M |
| Rd Expense | Q1 2025 · Mar 29, 2024 | $7.14M |
| Net Income | Q1 2025 · Mar 29, 2024 | $13.41M |
| Operating Income | Q1 2025 · Mar 29, 2024 | $22.25M |
| Gross Profit | Q1 2025 · Mar 29, 2024 | $71.21M |
| Cost Of Revenue | Q1 2025 · Mar 29, 2024 | $314.08M |
| Revenue | Q1 2025 · Mar 29, 2024 | $385.29M |